Measurement properties of the chinese language version of the functional assessment of cancer therapy-general in a singaporean population

Annals of the Academy of Medicine Singapore

Volumn 38, Issue 3, 2009, Pages 225-229

  Cheung, Yin Bun ^a,e   Goh, Cynthia ^b   Wee, Joseph ^b   Khoo, Kei Siong ^c   Thumboo, Julian ^d  

^a Clinical Trials   (Singapore)

^b DIVISION OF MEDICAL ONCOLOGY   (Singapore)

^c Parkway Hospitals Singapore   (Singapore)

^d SINGAPORE GENERAL HOSPITAL   (Singapore)

^e SCRI   (Singapore)

Author keywords

Quality of life; Reliability; Sensitivity; Validity

Indexed keywords

ADULT; ARTICLE; BREAST CANCER; CANCER EPIDEMIOLOGY; CANCER THERAPY; CHINESE; CLINICAL ASSESSMENT; COLORECTAL CANCER; CONTROLLED STUDY; FEMALE; GYNECOLOGIC CANCER; HEAD AND NECK CANCER; HUMAN; LANGUAGE; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; NASOPHARYNX CANCER; PATIENT ASSESSMENT; QUALITY OF LIFE; QUESTIONNAIRE; SINGAPORE; STATISTICAL SIGNIFICANCE; TEST RETEST RELIABILITY; WELLBEING;

EID: 64549146652     PISSN: 03044602     EISSN: 29724066     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Gondek K, Sagnier PP, Gilchrist K, Woolley JM. Current status of patient-report outcomes in industry-sponsored oncology clinical trials and product labels. J Clin Oncol 2007;25:5087-93.
2. United Nations. World Population Prospects: the 2000 Revision. New York: United Nations, 2001.
3. Tchen N, Bedard P, Yi QL, Klein M, Cella D, Eremenco S, et al. Quality of life and understanding of disease status among cancer patients of different ethnic origin. Br J Cancer 2003;89:641-7.
4. http://www.singstat.gov.sg. Accessed 8 January 2008.
5. Department ofStatistics. Singapore Census ofPopulation 2000 Statistical Release 2: Education, Language and Religion. Singapore: Department of Statistics, 2002.
6. Johnson JR, Williams G, Pazdur R. End points and United States Food and Drug Administration approval of oncology drugs. J Clin Oncol 2003;21:1404-11.
7. Yu CL, Fielding R, Chan CL, Tse VK, Choi PH, Lau WH, et al. Measuring quality of life of Chinese cancer patients: a validation of the Chinese version of the Functional Assessment of Cancer Therapy- General (FACT-G) scale. Cancer 2000;88:1715-27.
8. Eremenco SL, Hudgens S, Lau A, Lo P, Chang CH, Cella D. Cross- disease psychometric evaluation of the traditional Chinese FACT-G (Version 4). Conference abstract available at: http://www.isoqol.org/. Accessed 9 January 2008.
9. Goh CR, Lee KS, Tan TC, Wang TL, Tan CH, Wong J, et al. Measuring quality of life in difference cultures: translation of the Functional Living Index for Cancer (FLIC) into Chinese and Malay in Singapore. Ann Acad Med Singapore 1996;25:323-34.
10. Cheung YB, Ng GY, Wong LC, Koo WH, Tan EH, Tay MH, et al. Measuring quality of life in Chinese cancer patients: A new version of the Functional Living Index - Cancer (Chinese). Ann Acad Med Singapore 2003;32;376-80.
11. Cheung YB, Goh C, Thumboo J, Khoo KS, Wee J. Variability and sample size requirements of quality of life measures: A randomised study of three major questionnaires. J Clin Oncol 2005;23:4936-44.
12. Ruckdeschel JC, Piantadosi S. Quality of life in lung cancer surgical adjuvant trials. Chest 1994;106:324-8.
13. Blagden SP, Charman SC, Sharples LD, Magee LR, Gilligan D. Performance status score: Do patients and their oncologists agree? Br J Cancer 2003;89:1022-7.
14. Cella D. FACIT Manual: Manual of the Functional Assessment of Chronic Illness Therapy (FACIT) Measurement System. Evanston: CORE, 1997.
15. Cuzick J. A Wilcoxon-type test for trend. Stat Med 1985;4:87-90.
16. http://www.facit.org. Accessed 9 January 2008.
17. DeVelli RF. Scale Development: Theory and Applications. Newbury Park: Sage 1991.
18. Streiner DL, Norman GR. Health Measurement Scales. New York: Oxford University Press, 1989.
19. Cheung YB, Goh C, Thumboo J, Khoo KS, Wee J. Quality of life scores differed according to mode of administration in a review of three major oncology questionnaires. J Clin Epidemiol 2006;59:185-91.